Close Menu

NEW YORK — Sysmex and Riken Innovation said on Thursday that they have partnered to develop new diagnostic technologies and businesses, with a focus on diseases for which there are no established diagnostic methods.

Riken Innovation, a corporate subsidiary of Japanese research institute Riken, will provide its cross-disciplinary research results to the collaboration, while Sysmex will contribute its diagnostic research and development expertise. Technologies and businesses resulting from the alliance are expected to be rolled out globally, the companies said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.